Velicept raises another $15M to advance overactive bladder treatment
October 17, 2018 at 07:25 AM EDT
Velicept's series B financing has now brought in more than $30M for the Malvern pharmaceutical company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|